Clinical Trial Update: Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer [NA]

View source ↗

Summary

Clinical trial update on FLT-PET/CT as a biomarker of response for pemetrexed therapy in non-small cell lung cancer; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: University of Pennsylvania | Conditions: Non-small Cell Lung Cancer, Starting Pemetrexed Based Therapy | NA | Status: TERMINATED | Results posted: 2021-05-12